Salute e Benessere

Steam Trap Market worth $4.6 billion by 2028 - Exclusive Report by…

Browse in-depth TOC on "Steam Trap Market" 120 – Tables60 – Figures200 – Pages Browse in-depth TOC on "Steam Trap Market" 120 – Tables 60 – Figures 200 – Pages Steam Trap Market Report Scope: Mechanical steam trap segment to hold the largest size of the steam trap market during the forecast period. The mechanical steam trap segment is expected to account for the largest size of thesteam trap industrythroughout the forecast period. Mechanical steam traps detect the...
PR Newswire
30/08/2023

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted…

The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and olderRecommendation is based on pre-clinical data showing that the Omicron XBB.1.5-adapted monovalent COVID-19 vaccine generates an improved response against multiple XBB-related sublineages, including XBB.1.5, XBB.1.16, XBB.2.3, and EG.5.1 (Eris), which continue to dominate globally1Doses will be ready to ship to applicable EU member...
Nasdaq GlobeNewswire
30/08/2023

Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort

For more information:GEDiCube Press ReleaseFORWARD-LOOKING STATEMENT Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline. All statements other than historical facts are forward-looking statements, which can be identified by the...
Nasdaq GlobeNewswire
30/08/2023

XBiotech Announces Enrollment Completion of Phase II, Placebo Controlled…

/II randomized, double-blind, placebo-controlled clinical study for Natrunix in combination with chemotherapy for treating pancreatic cancer. Natrunix is indistinguishable from a naturally occurring antibody present in a healthy human. Natrunix binds and neutralizes a potent substance, a so called cytokine known as interleukin-1a (IL-1a), that causes connective tissue breakdown, growth of new blood vessels, and recruitment of white blood cells. Malignant tumors, like pancreatic cancer,...
Nasdaq GlobeNewswire
30/08/2023

Orion Corporation: Managers' transactions – Hilpi Rautelin

ORION CORPORATIONMANAGERS' TRANSACTIONS30 AUGUST 2023 at 15.30 EEST Orion Corporation: Managers' transactions – Hilpi Rautelin Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to...
Nasdaq GlobeNewswire
30/08/2023

European Society of Cardiology Congress: Traditional Chinese Medicine Qili…

Prof. Xinli Li pointed out that the results of the randomized, double-blind, placebo-controlled, multicenter clinical trial involving 3119 patients with chronic heart failure, conducted in 133 hospitals across mainland China and the Hong Kong SAR, over a treatment period of 12 to 36 months, revealed that Qili Qiangxin Capsules could reduce the risk of the primary composite endpoint event, which includes re-hospitalization due to worsening heart failure and cardiovascular death, by 22%. Prof...
PR Newswire
30/08/2023

Navamedic ASA - Registration of share capital increase

About Navamedic ASA About Navamedic ASA Navamedic ASA is a Nordic full-service provider of high-quality products to hospitals and through pharmacies. Navamedic meets the specific needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK andGreece. Navamedic is headquartered inOslo, Norway, and...
PR Newswire
30/08/2023

Alkermes Announces Settlement With Teva Related to VIVITROL® Patent Litigation

Additional details regarding the settlement agreement were not disclosed. The company and Teva will submit the settlement agreement for review to the United States Federal Trade Commission and the United States Department of Justice. Additional details regarding the settlement agreement were not disclosed. The company and Teva will submit the settlement agreement for review to the United States Federal Trade Commission and the United States Department of Justice. This patent litigation was...
PR Newswire
30/08/2023

OKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2 Clinical Trial of…

Full enrollment anticipated by first week of SeptemberOKYO on schedule to release top-line data before end of 2023Phase 2 trial is designed as potential registration trial with pre-specified primary efficacy endpoints covering both a sign and symptom of DED LONDON and NEW YORK, Aug.30, 2023(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat DED to address the significant unmet need in...
Nasdaq GlobeNewswire
30/08/2023

Maypharm Introduces its whole Lineups with Newly Launched products including…

Maypharm has become one of the leading players in the Korean dermocosmetics market, with a global network of distributors for its exclusive brands. Maypharm has become one of the leading players in the Korean dermocosmetics market, with a global network of distributors for its exclusive brands. Maypharm offers specialty medical supplies and medical-grade skin care products, including dermal fillers, botulinum toxin, mesotherapy products, cosmetics, and more. Maypharm's mission is to exceed...
PR Newswire
30/08/2023

yeedi cube: The Accessible Flagship for Hands-Free Clean, Made for Everyone

"We are excited to announce the yeedi cube, which represents a breakthrough for yeedi and the entire industry," said Gary Li, General Manager of yeedi. "Consumers are focusing on whether the robot can adequately address their cleaning needs and reduce their involvement in the cleaning process. And we have been thinking about how we can take the cleaning experience to the next level with tiny but creative add-on features. And, of course, with an even more accessible price, more and…
PR Newswire
30/08/2023

Novo Nordisk acquires Embark Biotech, including its lead asset targeting obesity…

The research and development collaboration with Embark Laboratories provide Novo Nordisk with the option to acquire selected assets based on the Embark Biotech discoveries across several indications, including obesity and type 2 diabetes. The research and development collaboration with Embark Laboratories provide Novo Nordisk with the option to acquire selected assets based on the Embark Biotech discoveries across several indications, including obesity and type 2 diabetes. Brian Finan,...
PR Newswire
30/08/2023

Immunovia Publishes Interim Report for January-June 2023

Significant events after the period Significant events after the period CEO's comments As announced in July, we are significantly restructuring Immunovia to focus on our novel next-generation test for detection of pancreatic cancer. These changes are difficult but necessary to improve the company's runway and strengthen our product offering. We continue to move quickly to streamline our operations, develop our next-generation test, and optimize our cost structure. Development of...
PR Newswire
30/08/2023

Johnson & Johnson Vision announces launch of ELITA™ Platform to Correct Myopia…

The ELITATM Platform enables surgeons to perform refractive correction on patients with myopia, with or without astigmatism, using the new SILK (Smooth Incision Lenticule Keratomileusis) procedure. With an ultra-precise laser pulse and fast laser delivery system, the ELITATM Platform provides surgeons with a consistently smooth and easy lenticular removal, offering exceptional vision correction with next-day results and recovery.1,2,3 TheELITA TMPlatformenables surgeons to perform...
PR Newswire
30/08/2023

The Future Landscapes Forum: Scientists and practitioners criticise 'dangerous'…

The group says these decisions disregard a large body of evidence showing that controlled burning can support wildfire prevention, carbon capture, and biodiversity improvement. Moreover, risks and impacts of alternatives like cutting or no vegetation management remain largely unknown and are often ignored. The group says these decisions disregard a large body of evidence showing that controlled burning can support wildfire prevention, carbon capture, and biodiversity improvement. Moreover,...
PR Newswire
30/08/2023

Zealand Pharma announces designation of priority review by the US FDA for…

Company announcement – No. 31 / 2023Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinismUS FDA has granted priority review designation to dasiglucagon for the prevention and treatment of hypoglycemia in pediatric patients 7 days of age and older with congenital hyperinsulinism (CHI) for up to 3 weeks of dosing with a Prescription Drug User Fee Act (PDUFA) date on December 30, 2023.To ensure the most efficient regulatory...
Nasdaq GlobeNewswire
30/08/2023

Mindray Introduces Innovative Upgrades to A Series Anaesthesia Systems for…

AnaeSight™ is Mindray's pioneering integrated solution for combined intravenous-inhalational anaesthesia. By connecting machines, patient monitors, and pumps, it enables centralized control over intravenous-inhalational anaesthetics. This allows anaesthesiologists to easily manage anaesthetics and monitor patient vital signs from multiple devices from one user-friendly interface, ensuring a comprehensive assessment of the patient's status and streamlines anaesthesia management. Additionally, the…
PR Newswire
30/08/2023

Coloplast A/S - Announcement no. 07/2023 – Coloplast announces completion of…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL. Coloplast announces completion of offering of 12.2 million new B shares in a directed issue and private placement On 29 August 2023 , Coloplast A/S (“Coloplast") announced its...
Nasdaq GlobeNewswire
30/08/2023

BioVaxys and The Ohio State University Extend Research Collaboration

There are growing concerns about the recently emerging Covid-19 variant EG.5 ("EG.5"). InJuly 2023, EG.5 became the dominant Covid-19 variant inthe United States. Along with the increasing global prevalence of EG.5, the World Health Organization ("WHO") recently classified EG.5 as a "variant of interest," meaning EG.5 is the result of genetic changes, and notably, has one particular mutation that is known to evade some of the immunity from a prior infection or…
PR Newswire
30/08/2023

Cutaneous Lupus Erythematosus Market is Expected to Surge at a CAGR of 7.2% by…

Key Takeaways from the Cutaneous Lupus Erythematosus Market Report Key Takeaways from the Cutaneous Lupus Erythematosus Market Report Discover which therapies are expected to grab the major cutaneous lupus erythematosus market share @Cutaneous Lupus Erythematosus Market Report Cutaneous Lupus Erythematosus Overview Cutaneous lupus erythematosus (CLE) is a subtype of lupus erythematosus, an autoimmune disorder that primarily affects the skin. Cutaneous lupus erythematosus...
PR Newswire
29/08/2023

Telesis Bio Appoints William J. Kullback Chief Financial Officer

“Bill's deep industry knowledge, operational expertise, and extensive financial experience make him ideally positioned to help lead us through the next phase of the Company's growth,” said Todd R. Nelson, PhD, CEO, and founder of Telesis Bio. “We are thrilled to welcome Bill to our team and excited to have another leader who brings both a strategic and operational mindset to creating shareholder value as we deliver researchers the tools they need to rapidly and securely design, code, and...
Nasdaq GlobeNewswire
29/08/2023

Lupin Launches Propranolol Long-Acting Capsules to Improve Heart Health in…

"We are delighted to announce the launch of Propranolol LA capsules for patients in Canada. We have diligently worked to build our portfolio to include Propranolol LA ensuring patients have access to the essential medicines. This launch signifies our commitment to fostering healthcare solutions that truly make a difference,"said Dr. Sofia Mumtaz, President – Legal, Canada, Australia, and Japan, Lupin. "We are delighted to announce the launch of Propranolol LA capsules for patients…
PR Newswire
29/08/2023

The opportunity within the Cannabis Testing Market is projected to grow at an…

Recent findings on the therapeutic applications of cannabis have led to increase in the number of players focused on developing cannabis-infused products for medical and recreational use. A number of product matrices infused with cannabis, including edibles, tinctures, salves and candles are being manufactured across the globe. Following this, the rise in cannabis testing service providers is also profound, catering to the regulatory requirements of these product manufacturers complying with the…
PR Newswire
29/08/2023

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as…

Disclosure of Share Capital and Voting Rights Outstandingas of July 31 , 2023(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)Charenton-le-Pont, France (August29 , 2023 - 6:00 pm)– As of July 31, 2023, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of...
Nasdaq GlobeNewswire
29/08/2023
Altri  Comunicati